Ayala Pharmaceuticals, Inc.

Ownership Transactions Reported by 10 Insiders

Symbol
ADXS on OTC
Industry
Pharmaceutical Preparations
Location
9 Deer Park Drive, Suite K 1, Monmouth Junction, New Jersey

There are no Buy or Sell transactions made by insiders since 9/12/2023

Ayala Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Israel Biotech Fund I, L.P. Director, 10%+ Owner $10.1M Mar 1, 2024
Yuval Cabilly Director $271K Oct 18, 2023
aMoon Growth Fund Limited Partnership 10%+ Owner $224K Oct 18, 2023
David Sidransky Director $56.00 Jan 19, 2023
Pini Orbach Director Oct 18, 2023
Vered Bisker-Leib Director Jan 19, 2023
Bridget Martell Director Oct 18, 2023
Robert J. Spiegel Director Jan 19, 2023
Murray A. Goldberg Director Jan 19, 2023
Roy Golan Chief Financial Officer Oct 18, 2023

Recent Insider Transactions by Companies or Individuals for Ayala Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.